Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omega-3 Fatty Acid Ethyl Esters (Lotriga) Granular Capsules Special Drug Use Surveillance (Long-term Use Survey)

NCT02153073 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02153073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02153073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omega-3 Fatty Acid Ethyl Esters (Lotriga) Granular Capsules Special Drug Use Surveillance (Long-term Use Survey)
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
May 29, 2013
Completion date
May 31, 2017
Enrollment
3,084 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia